Medline (MDLN) Preferred Stock Liabilities (2024)

Medline (MDLN) reported Preferred Stock Liabilities of $366.0 million for Q4 2024.

Medline (MDLN) has 1 years of Preferred Stock Liabilities data on file, last reported at $366.0 million in Q4 2024.

  • Quarterly Preferred Stock Liabilities changed N/A year-over-year to $366.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $366.0 million (changed N/A YoY) and the FY2024 annual result came in at $366.0 million, up 57.08% from the prior year.
  • Preferred Stock Liabilities was little changed at $366.0 million in Q4 2024 per MDLN's latest filing.
  • Across five years, Preferred Stock Liabilities topped out at $366.0 million in Q4 2024 and bottomed at $366.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Intuitive Surgical 146.28 Bn 141.88 Bn 1.83 Bn -
2 Becton Dickinson 41.14 Bn 40.13 Bn 2.15 Bn -
3 Medline 29.16 Bn 35.00 Bn 1.84 Bn -
4 Resmed 27.13 Bn 25.47 Bn 890.98 Mn -
5 West Pharmaceutical Services 22.71 Bn 22.19 Bn 296.40 Mn -
6 Solventum 13.26 Bn 13.26 Bn 1.10 Bn -
7 Align Technology 12.22 Bn 11.16 Bn 736.59 Mn -
8 Cooper Companies 11.79 Bn 11.66 Bn 695.20 Mn -
9 Baxter International 9.47 Bn 7.42 Bn 891.00 Mn -
10 Aptargroup 7.19 Bn 6.99 Bn 351.91 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 366.00 Mn